Meta-analysis: Effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes

Annals of Internal Medicine

Volumn 154, Issue 7, 2011, Pages 472-482

  Bloomfield, Hanna E ^a   Krause, Ange ^a   Greer, Nancy ^a   Taylor, Brent C ^a   MacDonald, Roderick ^a   Rutks, Indulis ^a   Reddy, Preetham ^a   Wilt, Timothy J ^a  

^a Minneapolis Veterans Affairs Health Care System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K;

ANTICOAGULANT THERAPY; BLEEDING; COCHRANE LIBRARY; HUMAN; MEDLINE; META ANALYSIS; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SELF CARE; SELF EVALUATION; SYSTEMATIC REVIEW; THROMBOEMBOLISM;

EID: 79955432126     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-154-7-201104050-00005     Document Type: Review

References (54)

1. Hirsh J, Guyatt G, Albers GW, Harrington R, Schnemann HJ; American College of Chest Physicians. Executive summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:71S-109S. [PMID: 18574259]
2. Beauregard KM, Carper K. Outpatient prescription anticoagulants utilization and expenditures for the U.S. civilian noninstitutionalized population age 18 and older, 2007. Statistical Brief #268. 2009. Accessed at www.meps.ahrq.govepsweb/data_files/publications/st268/stat268.shtml on 25 August 2010.
3. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139-1151. [PMID: 19717844]
4. Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, et al; RE-COVER Study Group. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med. 2009;361:2342-2352. [PMID: 19966341]
5. Cios DA, Baker WL, Sander SD, Phung OJ, Coleman CI. Evaluating the impact of study-level factors on warfarin control in U.S.-based primary studies: a meta-analysis. Am J Health Syst Pharm. 2009;66:916-925. [PMID: 19420310]
6. Connock M, Stevens C, Fry-Smith A, Jowett S, Fitzmaurice D, Moore D, et al. Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling. Health Technol Assess. 2007;11:3-4, 9-66. [PMID: 17903392]
7. Oertel LB, Libby EN. Is patient self-testing a good thing? J Thromb Throm-bolysis. 2010;29:214-218. [PMID: 19902148]
8. CMS Medicare Coverage Database. Decision memo for prothrombin time (INR) monitor for home anticoagulation measurement (CAG-00087R); 2008. Accessed at www.cms.gov/mcd/viewdecisionmemo.asp?from2=viewdecisionmemo.asp&id=209&on 9 December 2010.
9. Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A, et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet. 1996;348:423-428. [PMID: 8709780]
10. Sawicki PT. A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA. 1999; 281:145-1450. [PMID: 9917117]
11. Menendez-Jandula B, Souto JC, Oliver A, Montserrat I, Quintana M, Gich I, et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Ann Intern Med. 2005;142:1-10. [PMID: 15630104]
12. Kortke H, Minami K, Breymann T, Seifert D, Baraktaris A, Wagner O, et al. [INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial)]. Z Kardiol. 2001;90 Suppl 6:118-24. [PMID: 11826814]
13. Kortke H, Korfer R. International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous? Ann Thorac Surg. 2001;72:44-48. [PMID: 11465228]
14. Kortke H, Zittermann A, Wagner O, Koerfer R. Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement. Ann Thorac Surg. 2007;83:24-29. [PMID: 17184625]
15. Dauphin C, Legault B, Jaffeux P, Motreff P, Azarnoush K, Joly H, et al. Comparison of INR stability between self-monitoring and standard laboratory method: preliminary results of a prospective study in 67 mechanical heart valve patients. Arch Cardiovasc Dis. 2008;101:753-761. [PMID: 19059570]
16. Siebenhofer A, Rakovac I, Kleespies C, Piso B, Didjurgeit U. Self- management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Thromb Haemost. 2007;97:408-416. [PMID: 17334508]
17. Siebenhofer A, Rakovac I, Kleespies C, Piso B, Didjurgeit U; SPOG 60+ Study Group. Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial. Thromb Haemost. 2008;100:1089-1098. [PMID: 19132235]
18. Soliman Hamad MA, van Eekelen E, van Agt T, van Straten AH. Self-management program improves anticoagulation control and quality of life: a prospective randomized study. Eur J Cardiothorac Surg. 2009;35:265-269. [PMID: 19041254]
19. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408-412. [PMID: 7823387]
20. Owens DK, Lohr KN, Atkins D, Treadwell JR, Reston JT, Bass EB, et al. AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions-agency for healthcare research and quality and the effective health-care program. J Clin Epidemiol. 2010;63:513-523. [PMID: 19595577]
21. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560. [PMID: 12958120]
22. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634. [PMID: 9310563]
23. Beyth RJ, Quinn L, Landefeld CS. A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Ann Intern Med. 2000;133:687-695. [PMID: 11074901]
24. Matchar DB, Jacobson A, Dolor R, Edson R, Uyeda L, Phibbs CS, et al; THINRS Executive Committee and Site Investigators. Effect of home testing of international normalized ratio on clinical events. N Engl J Med. 2010;363:1608-1620. [PMID: 120961244]
25. Sunderji R, Gin K, Shalansky K, Carter C, Chambers K, Davies C, et al. A randomized trial of patient self-managed versus physician-managed oral anticoagulation. Can J Cardiol. 2004;20:1117-1123. [PMID: 15457308]
26. Cromheecke ME, Levi M, Colly LP, de Mol BJ, Prins MH, Hutten BA, et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet. 2000;356: 97-102. [PMID: 10963245]
27. Fitzmaurice DA, Murray ET, Gee KM, Allan TF, Hobbs FD. A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. J Clin Pathol. 2002;55:845-849. [PMID: 12401823]
28. Gadisseur AP, Breukink-Engbers WG, van der Meer FJ, van den Besselaar AM, Sturk A, Rosendaal FR. Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anti-coagulation clinics in the Netherlands: a randomized clinical trial. Arch Intern Med. 2003;163:2639-2646. [PMID: 14638565]
29. Gadisseur AP, Kaptein AA, Breukink-Engbers WG, van der Meer FJ, Rosendaal FR. Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. J Thromb Haemost. 2004;2:584-591. [PMID: 15102012]
30. Gardiner C, Williams K, Mackie IJ, Machin SJ, Cohen H. Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. Br J Haematol. 2005;128:242-247. [PMID: 15638860]
31. Christensen TD, Maegaard M, Sørensen HT, Hjortdal VE, Hasenkam JM. Self-management versus conventional management of oral anticoagulant therapy: a randomized, controlled trial. Eur J Intern Med. 2006;17:260-266. [PMID: 16762775]
32. Christensen TD, Maegaard M, Sørensen HT, Hjortdal VE, Hasenkam JM. Self- versus conventional management of oral anticoagulant therapy: effects on INR variability and coumarin dose in a randomized controlled trial. Am J Car-diovasc Drugs. 2007;7:191-197. [PMID: 17610346]
33. Gardiner C, Williams K, Longair I, Mackie IJ, Machin SJ, Cohen H. A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing. Br J Haematol. 2006;132:598-603. [PMID: 16445833]
34. Ryan F, Byrne S, O'Shea S. Randomized controlled trial of supervised patient self-testing of warfarin therapy using an internet-based expert system. J Thromb Haemost. 2009;7:1284-1290. [PMID: 19496921]
35. Fitzmaurice DA, Murray ET, McCahon D, Holder R, Raftery JP, Hussain S, et al. Self management of oral anticoagulation: randomised trial. BMJ. 2005; 331:1057. [PMID: 16216821]
36. Jowett S, Bryan S, Murray E, McCahon D, Raftery J, Hobbs FD, et al. Patient self-management of anticoagulation therapy: a trial-based cost-effectiveness analysis. Br J Haematol. 2006;134:632-639. [PMID: 16938120]
37. Horstkotte D, Piper C, Wiemer M, Schulte HD, Schultheiss H-P. Improvement of prognosis by home prothrombin estimation in patients with lifelong anticoagulation therapy [Abstract]. Eur Heart J. 1996;17 Suppl:230.
38. Horstkotte D, Piper C, Wiemer M. Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. J Thromb Thrombolysis. 1998;5 Suppl 1:19-24. [PMID: 10767128]
39. Sidhu P, O'Kane HO. Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Ann Thorac Surg. 2001; 72:1523-1527. [PMID: 11722037]
40. Eitz T, Schenk S, Fritzsche D, Bairaktaris A, Wagner O, Koertke H, et al. International normalized ratio self-management lowers the risk of thromboem-bolic events after prosthetic heart valve replacement. Ann Thorac Surg. 2008;85: 949-954. [PMID: 18291177]
41. Khan TI, Kamali F, Kesteven P, Avery P, Wynne H. The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. Br J Haematol. 2004;126:557-564. [PMID: 15287950]
42. Voller H, Glatz J, Taborski U, Bernardo A, Dovifat C, Heidinger K. Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study). Z Kardiol. 2005;94:182-186. [PMID: 15747040]
43. Heneghan C, Alonso-Coello P, Garcia-Alamino JM, Perera R, Meats E, Glasziou P. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet. 2006;367:404-411. [PMID: 16458764]
44. Christensen TD, Johnsen SP, Hjortdal VE, Hasenkam JM. Self- management of oral anticoagulant therapy: a systematic review and meta-analysis. Int J Cardiol. 2007;118:54-61. [PMID: 16891008]
45. Garcia-Alamino JM, Ward AM, Alonso-Coello P, Perera R, Bankhead C, Fitzmaurice D, et al. Self-monitoring and self-management of oral anticoagula-tion. Cochrane Database Syst Rev. 2010:CD003839. [PMID: 20393937]
46. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G; American College of Chest Physicians. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133:160S-198S. [PMID: 18574265]
47. Oake N, Jennings A, Forster AJ, Fergusson D, Doucette S, van Walraven C. Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis. CMAJ. 2008;179:235-244. [PMID: 18663203]
48. van Walraven C, Oake N, Wells PS, Forster AJ. Burden of potentially avoidable anticoagulant-associated hemorrhagic and thromboembolic events in the elderly. Chest. 2007;131:1508-1515. [PMID: 17317732]
49. Connolly SJ, Pogue J, Eikelboom J, Flaker G, Commerford P, Franzosi MG, et al; ACTIVE W Investigators. Benefit of oral anticoagulant over anti-platelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range. Circulation. 2008;118:2029-2037. [PMID: 18955670]
50. Jones M, McEwan P, Morgan CL, Peters JR, Goodfellow J, Currie CJ. Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population. Heart. 2005;91:472-477. [PMID: 15772203]
51. Veeger NJ, Piersma-Wichers M, Tijssen JG, Hillege HL, van der Meer J. Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. A retrospective study of 2300 consecutive patients with venous thromboembo-lism. Br J Haematol. 2005;128:513-519. [PMID: 15686461]
52. White HD, Gruber M, Feyzi J, Kaatz S, Tse HF, Husted S, et al. Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. Arch Intern Med. 2007; 167:239-245. [PMID: 17296878]
53. Wittkowsky AK, Sekreta CM, Nutescu EA, Ansell J. Barriers to patient self-testing of prothrombin time: national survey of anticoagulation practitioners. Pharmacotherapy. 2005;25:265-269. [PMID: 15767240]
54. Ansell J, Jacobson A, Levy J, Voller H, Hasenkam JM; International Self-Monitoring Association for Oral Anticoagulation. Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation. Int J Cardiol. 2005;99:37-45. [PMID: 15721497]